GoodRx offers Eli Lilly's new oral GLP-1 drug at $149 monthly
Go back to GoodRx offers Eli Lilly's new oral GLP-1 drug at $149 monthly| (NASDAQ: GDRX) | Delayed: 2.57 -0.09 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.66 | 52 Week High | $ | |||
| Open | $2.64 | 52 Week Low | $ | |||
| Day High | $2.71 | P/E | N/A | |||
| Day Low | $2.57 | EPS | $ | |||
| Volume | 1,869,184 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1102.08 +3.51 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 255.11 | |||
| Day Low | $1093.15 | EPS | $4.32 | |||
| Volume | 3,014,837 | |||||
